- Report
- February 2024
- 250 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Clinical Trials
- April 2024
- 240 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Report
- August 2023
- 295 Pages
Global
From €9128EUR$9,500USD£7,804GBP
- Report
- January 2024
- 243 Pages
Global
€4799EUR$4,995USD£4,103GBP
From €300EUR$334USD£265GBP
- Report
- October 2022
- 270 Pages
Global
From €3603EUR$3,750USD£3,080GBP
- Report
- September 2022
- 232 Pages
Global
From €3363EUR$3,500USD£2,875GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2642EUR$2,750USD£2,259GBP
- Report
- September 2022
- 282 Pages
Global
From €9128EUR$9,500USD£7,804GBP
- Report
- August 2022
- 30 Pages
Global
From €2642EUR$2,750USD£2,259GBP
- Report
- January 2022
- 112 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- August 2022
- 118 Pages
Global
From €4324EUR$4,500USD£3,697GBP
- Report
- May 2021
- 50 Pages
China
From €2498EUR$2,600USD£2,136GBP
- Report
- August 2018
- 34 Pages
Global
From €9608EUR$10,000USD£8,215GBP
- Report
- September 2020
- 148 Pages
Global
From €10564EUR$10,995USD£9,032GBP
- Report
- August 2018
- 679 Pages
Global
From €21139EUR$22,000USD£18,072GBP
- Report
- April 2022
- 76 Pages
North America
From €1441EUR$1,500USD£1,232GBP
- Report
- October 2018
- 50 Pages
Global
From €8162EUR$8,495USD£6,978GBP
- Report
- April 2023
- 113 Pages
Global
€3363EUR$3,500USD£2,875GBP
- Report
- April 2018
United States
From €7682EUR$7,995USD£6,568GBP
Stelara is a biologic drug used to treat immune disorders such as psoriasis, Crohn's disease, and ulcerative colitis. It is a monoclonal antibody that works by blocking the action of two proteins, interleukin 12 and interleukin 23, which are involved in the body's inflammatory response. Stelara is administered as an injection or infusion, and is typically used in combination with other medications.
Stelara is a relatively new drug, having been approved by the US Food and Drug Administration in 2009. It has become a popular treatment option for immune disorders due to its effectiveness and relatively low side effects.
The Stelara market is highly competitive, with several major pharmaceutical companies offering their own versions of the drug. These include Johnson & Johnson, AbbVie, Merck, and Pfizer. Other companies, such as Amgen and Biogen, are also developing their own versions of the drug. Show Less Read more